Cervical Intraepithelial Neoplasia (CIN; Dysplasia of the Cervix)

Key points
- The squamocolumnar junction of the cervix is an area of active squamous cell proliferation.
- There are no specific symptoms or signs of cervical intraepithelial neoplasia.
- Cytologic Examination (Papanicolaou Smear) Specimens should be taken from a nonmenstruating patient, spread on a single slide, and fixed or rinsed directly into preservative solution if a thin layer slide system (ThinPrep) is to be used.
- Current data suggest that cervical infection with the human papillomavirus (HPV) is associated with a high percentage of all cervical dysplasias and cancers.
Introduction
Essentials of Diagnosis
- The presumptive diagnosis is made by an abnormal Pap smear of an asymptomatic woman with no grossly visible cervical changes.
- Diagnose by colposcopically directed biopsy.
- Increased in women with HIV.
General Considerations
The squamocolumnar junction of the cervix is an area of active squamous cell proliferation. In childhood, this junction is located on the exposed vaginal portion of the cervix. At puberty, because of hormonal influence and possibly because of changes in the vaginal pH, the squamous margin begins to encroach on the single-layered, mucus-secreting epithelium, creating an area of metaplasia (transformation zone). Factors associated with coitus (see Prevention, below) may lead to cellular abnormalities, which over a period of time can result in the development of squamous cell dysplasia or cancer. There are varying degrees of dysplasia (Table 17-2), defined by the degree of cellular atypia; all types must be observed and treated if they persist or become more severe. At present, the malignant potential of a specific lesion cannot be predicted. Some lesions remain stable for long periods of time some regress, and others advance.
Clinical Findings
There are no specific symptoms or signs of cervical intraepithelial neoplasia. The presumptive diagnosis is made by cytologic screening of an asymptomatic population with no grossly visible cervical changes. All visibly abnormal cervical lesions should be biopsied.
Diagnosis
A. Cytologic Examination (Papanicolaou Smear)
Specimens should be taken from a nonmenstruating patient, spread on a single slide, and fixed or rinsed directly into preservative solution if a thin layer slide system (ThinPrep) is to be used. A specimen should be obtained from the squamocolumnar junction with a wooden or plastic spatula and from the endocervix with a cotton swab or nylon brush.
Cytologic reports from the laboratory may describe findings in one of several ways (see Table 17-2). While use of class I-IV is now rare, the CIN classification continues to be used along with a description of abnormal cells, including evidence of human papillomavirus (HPV). The Bethesda System uses the terminology "squamous intraepithelial lesions (SIL)," low-grade or high-grade. Cytopathologists consider a Pap smear to be a medical consultation and will recommend further diagnostic procedures, treatment for infection, and comments on factors preventing adequate evaluation of the specimen. Reflex HPV testing of thin layer cytologic smears may be useful for triage of atypia (atypical squamous cells of unknown significance; ASC-US).
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsHighly educated women stop smoking if the cost goes up
Cigarette prices and images on cigarette packets have an impact on women in terms of continuing to smoke or quitting. In fact, less educated women are more responsive to pictorial labels on cigarette packets, as…
20 June 2015
NewsEndometriosis associated with a greater risk of complications in pregnancy
Women with endometriosis are at an increased risk of miscarriage and ectopic pregnancy, according to results of a huge nationwide study presented today. Moreover, women with a history of endometriosis whose pregnancies…
16 June 2015
NewsNearly 10 percent of women live too far from access to gynecologic cancer care
More than one-third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly…





